BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1967132)

  • 1. Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
    Fasching CE; Peterson LR; Moody JA; Sinn LM; Gerding DN
    J Lab Clin Med; 1990 Nov; 116(5):697-706. PubMed ID: 1967132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
    Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
    Ferrer C; Rodríguez A; Abad JL; Fernandez J; Alió JL
    Br J Ophthalmol; 2008 May; 92(5):678-82. PubMed ID: 18211926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
    Boisson K; Thouverez M; Talon D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
    Backo M; Gaenger E; Burkart A; Chai YL; Bayer AS
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2565-8. PubMed ID: 10508047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
    Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
    J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
    J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM; Thauvin-Eliopoulos C; Moellering RC
    Clin Infect Dis; 1992 Jul; 15(1):58-62. PubMed ID: 1319757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo.
    Darouiche RO; Mansouri MD
    J Infect; 2005 Apr; 50(3):206-9. PubMed ID: 15780414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin.
    Rybak MJ; Cha R; Cheung CM; Meka VG; Kaatz GW
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):119-25. PubMed ID: 15698717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.